Q3 2025 Management View Stéphane Bancel, CEO, reported third quarter revenue of $1 billion, driven by sales of fully approved vaccines including Spikevax, mNEXSPIKE, and mRESVIA, and announced a net ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback